Therapy Areas: Infectious Diseases
AstraZeneca acquires biotechnology company Omniose to strengthen vaccine capabilities
10 November 2026 - Preclinical biotechnology company Omniose announced on Tuesday that it has been acquired by biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN).This acquisition...
bioMérieux secures FDA clearance and IVDR CE marking for VITEK PRO diagnostic platform
10 November 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Tuesday that it has received US Food and Drug Administration (FDA) 510(k) clearance and European IVDR ...
INOVIO prices public offering of approximately USD75m
6 November 2026 - INOVIO Pharmaceuticals Inc (Nasdaq:INO), a biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, c...
INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP
2 November 2026 - INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectiou...
Solventum's combined use of Restrata Matrix and Solventum VAC Therapy receives FDA 510(k) clearance
20 October 2026 - Solventum Corporation (NYSE: SOLV), a US-based company involved in advanced wound healing, announced on Monday that the US Food and Drug Administration (FDA) has granted 510(k) clear...
ABL Texcell Diagnostics acquires IntegraGen assets to expand into precision oncology
12 October 2026 - ABL Texcell Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, said on Monday that it has acquired IntegraGen's assets and business operations following a...